RedHill Biopharma (RDHL) Accumulated Expenses (2016 - 2026)
RedHill Biopharma (RDHL) posted Accumulated Expenses of $12.02 million for the quarter ended Dec 31, 2025, up 20.2% from $9.99 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Accumulated Expenses (2016 - 2026) Analysis & Trends
Since the quarter ended Dec 31, 2016, RedHill Biopharma has reported Accumulated Expenses for 31 quarters.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of -13.0% (years ended Dec 2020 to Dec 2025).
- In prior years, RedHill Biopharma's Accumulated Expenses was $9.99 million in the year ended Dec 31, 2024 (+117.6%), $4.59 million in the year ended Dec 31, 2023 (-74.4%), $17.95 million in the year ended Dec 31, 2022 (-14.1%) and $20.9 million in the year ended Dec 31, 2021 (-13.2%).
- The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly Accumulated Expenses since the quarter ended Mar 31, 2023.
- On a year-over-year basis, Accumulated Expenses increased in three of the last four quarters, with growth averaging 65.3%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was the quarter ended Jun 30, 2025, with growth of 169.8%; the weakest was the quarter ended Dec 31, 2023, with a decline of 74.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.67 Mn |
| Dec 31, 2025 | 12.02 Mn |
| Jun 30, 2025 | 10.69 Mn |
| Dec 31, 2024 | 9.99 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 17.13 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Sep 30, 2022 | 21.20 Mn |
| Jun 30, 2022 | 20.21 Mn |
| Mar 31, 2022 | 24.15 Mn |
| Dec 31, 2021 | 20.90 Mn |
| Sep 30, 2021 | 20.59 Mn |
| Jun 30, 2021 | 23.16 Mn |
| Mar 31, 2021 | 25.45 Mn |
| Dec 31, 2020 | 24.08 Mn |
| Sep 30, 2020 | 23.54 Mn |
| Jun 30, 2020 | 29.19 Mn |
| Mar 31, 2020 | 12.91 Mn |
API Access
RedHill Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();